Business ❯ Healthcare ❯ Pharmaceuticals

Vaccines

Bavarian Nordic Public Health Innovative Vaccines mRNA Technology Influenza Vaccines Market Dynamics Market Competition Corporate Social Responsibility Infectious Diseases Covid Vaccine Development COVID-19 COVID-19 Vaccines Moderna Bavarian Nordic A/S Gardasil Covid-19 Valneva SE

5 ARTICLES

2mo ago

Moderna Restructures Leadership as It Prepares for Multiple Vaccine Launches

The company expanded Stephen Hoge’s remit and hired a chief commercial officer to build the operations needed to move its mRNA candidates from trials to market.